COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER STEM CELLS
The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof: Formula (I).
-
Page/Page column 52
(2013/03/28)
Identification of a selective small molecule inhibitor of breast cancer stem cells
A high-throughput screen (HTS) with the National Institute of Health-Molecular Libraries Small Molecule Repository (NIH-MLSMR) compound collection identified a class of acyl hydrazones to be selectively lethal to breast cancer stem cell (CSC) enriched pop
Germain, Andrew R.,Carmody, Leigh C.,Morgan, Barbara,Fernandez, Cristina,Forbeck, Erin,Lewis, Timothy A.,Nag, Partha P.,Ting, Amal,Verplank, Lynn,Feng, Yuxiong,Perez, Jose R.,Dandapani, Sivaraman,Palmer, Michelle,Lander, Eric S.,Gupta, Piyush B.,Schreiber, Stuart L.,Munoz, Benito
supporting information; experimental part
p. 3571 - 3574
(2012/07/03)
More Articles about upstream products of 1378872-36-6
